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Singh & Fitzgerald (2010): BoNT/A was associated with 
significantly greater reduction in pain compared to the control at four 
to six weeks; estimated significance MD -0.9 favoring BoNT/A over 
placebo (95% CI -1.8 to -0.1; p= 0.03). External rotation improved 
significantly more in the BoNT/A group compared to the control in 
three RCTs at four to six weeks (MD 9.79°). No significant 
differences were noted in muscle spasticity, adverse events, 
shoulder flexion or shoulder abduction. Interpretation of these 
findings is limited due to few studies with small sample sizes.
4 Apply: Conclusions for Practice 
Hoare & Imms (2004): BoNT/A injections temporarily decrease tone 
creating opportunity for therapists to impact ROM, reduce deformity, 
and make functional gains. Research supports BoNT/A injections 
adjunct therapy achieves clinically significant gains in children with 
spastic cerebral palsy with minimal risks, but not all individuals will 
benefit. Further research with defined therapy protocols, valid and 
reliable assessment tools, and multiple injections is necessary for 
efficacy of specified therapeutic intervention techniques adjunct 
BoNT/A injections (Hoare & Imms, 2004).
Singh & Fitzgerald (2010): BoNT/A injections may be useful in 
decreasing shoulder pain and increasing external rotation in patients 
post-stroke; this allows patients to withstand further stretching, reach 
greater functional changes and engage more independently in 
occupational activities. More studies with larger sample sizes and 
longer follow ups are needed to confirm these findings before 
BoNT/A can be fully supported as an effective intervention for 
patients with shoulder pain associated with hemiplegia.
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BoNT/A injections coupled with therapy reduce pain and 
tone and increase active range of motion and function in 
individuals with hypertonicity. 
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1 Ask: Research Question 
What are the benefits and risks of using BoNT/A injections to manage 
tone?
2a Acquire: Search Terms
Databases: ProQuest, PubMed, ClinicalKey
● Patient/Client Group: Hypertonicity
● Intervention: Intramuscular Botulinum Toxin-A injections
● Comparison:  Placebo Injection or another active OT treatment
● Outcome(s): Pain, tone, active range of motion (AROM), disability or
function
2b Acquire: Selected Articles 
Hoare & Imms (2004): Systematic review of BoNT/A injections to reduce 
tone and improve upper extremities functional use in children with 
cerebral palsy.
Singh & Fitzgerald (2010): Systematic review and meta-analysis 
investigating the efficacy and safety of BoNT/A compared to placebo or 
active treatment in people with post-stroke shoulder pain.
3a Appraise: Study Quality        
Hoare & Imms (2004): Level one evidence including two randomized 
control trials (RCT), four case studies, and nine single group designs. 
Studies used varied assessment tools but some lacked reliability and 
validity. RCT1 was double blind but limited by small sample size (n=14). 
RCT2 was single blind but used reliable and valid functional measures. 
Most of the single group designs poorly controlled for confounding 
variables. No study clearly defined occupational therapy (OT) 
interventions used, which limits reproducibility.
Singh & Fitzgerald (2010): Level one evidence. Twenty-one studies 
qualified for full review, 15 were excluded for myofascial pain. Six 
studies met the inclusion criteria, labeled as “double-blind” RCT’s. 
Sample size n= 17-43 participants. Most of the studies did not use valid 
and reliable outcome measures. Four of the six studies were partially 
funded by the makers of BoNT/A. Interventions were not consistent 
between studies and outcome measurements were not clearly defined. 
3b Appraise: Study Results 
Hoare & Imms (2004): RCT1 demonstrated statistically significant 
(p<.05) improvements in tone and spasticity of the wrist and elbow, 
AROM elbow extension and thumb extension, and grasp and release 
scores. RCT2 found statistically significant improvements in quality of 
movement and functional ability in self care; 13.3% ^ in QUEST score & 
PEDI (F=4.68, df=1,82; p=.04). Single group designs demonstrated 
statistically significant improvement in spasticity, ROM, fine motor skills, 
disability, and self care skills. Temporary adverse effects included two 
cases of excessive localized weakness and two cases of generalized 
upper extremity weakness.
(Spinal Cord Injury BC, 2019)
Background Information:
Botulinum Toxin-A (BoNT/A) is being used as an adjunct to therapy to 
reduce focal spasticity, increase range of motion (ROM), manage pain, 
improve function, and possibly delay surgical intervention (Hoare & Imms, 
2004). BoNT/A inhibits acetylcholine release at the neuromuscular junction 
resulting in temporary denervation and decreased muscular activity. 
Reinnervation eventually restores muscle function. Adverse effects include 
excessive weakness and atrophy of injected muscle, unintended 
weakness in adjacent muscles, and immunoresistance to BoNT/A 
(Ghasemi, Salari, Khorvash, & Shaygannejad, 2013).
